To Observe the CD7-targeted CAR-T Therapy in the Treatment of r/r PTCL

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 18, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

December 31, 2027

Conditions

CD7 Positive R/R PTCL

Interventions

DRUG

CAR-T

autologous CD7-targeted CAR-T cells, single injection

Trial Locations (1)

RECRUITING

Peking University People's Hospital, Beijing

All Listed Sponsors

lead

Peking University People's Hospital

OTHER

NCT07143929 - To Observe the CD7-targeted CAR-T Therapy in the Treatment of r/r PTCL | Biotech Hunter | Biotech Hunter